Safinamide Synthesis via One-Pot Imine Reduction

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing processes for preparing safinamide and its salts often result in low yields and impurities, requiring the use of very pure intermediates and additional purification steps, which are not suitable for industrial-scale production.

Innovation Solution

A process involving the reaction of 4-[(3-fluorobenzyl)oxy]benzaldehyde with (S)-2-aminopropanamide in a C1-C5 lower alkanol, followed by reduction in the same reactor, without isolating the imine intermediate, to produce safinamide with high enantiomeric and chemical purity, using a hydride in a specific ratio of C1-C5 alkanol to imine, and converting the free base to a salt with an acid.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If sequential iminoalkylation and reduction steps are used with isolation of imine intermediate, then purity can be maintained, but productivity decreases and process complexity increases

Engineering Contradiction:
ImprovepurityVSAvoidyield
Core Design Contradiction:
Manufacturing precisionVSProductivity

Solution Approach 1:

The patent combines the iminoalkylation and reduction steps into a single one-pot process. The aldehyde reacts with the amine to form the imine intermediate in situ, which is then immediately reduced by sodium cyanoborohydride without isolation. This merging of operations eliminates the time loss and material loss associated with isolation while maintaining purity through controlled reaction conditions.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The patent maintains continuous useful action by performing the reduction step immediately after imine formation in the same reactor without breaking the process flow. The imine intermediate is not isolated but is directly reduced in situ, ensuring continuous production and eliminating idle time between steps, thereby improving productivity while maintaining manufacturing precision.

Inventive Principle:
Principle #20Continuity of useful action

2Manufacturing precision

If multiple purification steps are added to remove impurities, then purity increases, but device complexity and loss of substance increase

Engineering Contradiction:
ImprovepurityVSAvoidloss
Core Design Contradiction:
Manufacturing precisionVSLoss of substance

Solution Approach 1:

The patent converts the potentially harmful impurity (imine intermediate that could lead to side products) into a beneficial step by using it as the substrate for the reduction reaction. The imine formed in situ is directly reduced to the desired amine product, transforming what would be a purification problem into an efficient one-pot synthesis approach that minimizes material loss.

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

3Manufacturing precision

If very pure intermediates are used, then final product purity is maintained, but loss of substance and process complexity increase

Engineering Contradiction:
ImprovepurityVSAvoidprocess complexity
Core Design Contradiction:
Manufacturing precisionVSDevice complexity

Solution Approach 1:

The patent segments the reaction process into two distinct functional steps performed in one pot: iminoalkylation to form the imine intermediate, and reduction to form the final amine product. This segmentation allows each step to be optimized independently while maintaining overall simplicity, avoiding the need for separate purification operations and reducing process complexity.

Inventive Principle:
Principle #1Segmentation

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This process achieves high yields and high purity of safinamide and its salts without the need for very pure intermediates or additional purification steps, making it suitable for industrial-scale production with reduced impurity levels.

Implementation Method 1

reduction with a hydride the obtained (S)-2-{{4-[(3-fluorobenzyl)oxy]benzylidene}amino}propanamide (compound IV) in a C1-C5 lower alkanol

Methodology Applied
Scientific EffectReduction: Reduction

Implementation Method 2

reducing with a hydride the obtained (S)-2-{{4-[(3-fluorobenzyl)oxy]benzylidene}amino}propanamide (compound IV) in a C1-C5 lower alkanol

Methodology Applied
Scientific EffectSolvation: Solvation

Data Source

PatentEP3772510B1Process for preparing safinamide
Publication Date: 2024.02.14 MEDICHEM SA
  • EP3772510B1 patent drawingFigure 1
  • EP3772510B1 patent drawingFigure 2
  • EP3772510B1 patent drawingFigure 3

AI summary

The present invention is related to a process for preparing safinamide and salts thereof, preferably safinamide methanesulfonate, with high yields and high enantiomeric and chemical purity without the need of using highly pure intermediates. The process of the present invention is suitable for the production of safinamide and its salts, preferably safinamide methanesulfonate, at industrial scale.